Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0000950170-25-080311

Director sold 2,783 shares at $7.35 ($20,465)

  • Director acquired 4,800 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Jenkins John Kenneth · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-05-30 Sale : show line 1 in the form 10b5-1 −2,783 $7.35 $20,465 33 D
2025-05-30 Grant or award : show line 2 in the form 10b5-1 +4,800 4,833 D
Open-market sales · 2,783 sh · avg $7.35 · $20,465

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-05-30 Grant or award : show line 3 in the form 10b5-1 Stock options (right to buy) +16,000 16,000 D
Loading xslF345X05/ownership.xml…